<DOC>
	<DOCNO>NCT01554397</DOCNO>
	<brief_summary>The purpose study find whether patient cervical cancer treat IMRT less side effect equal cancer control compare standard radiation technique . With standard radiation technique , normal pelvic organ near tumor receive radiation dose , lead side effect . IMRT new radiation technique reduce radiation dose organ may reduce side effect . Compared conventional RT technique , hypothesis IMRT reduce acute hematologic gastrointestinal toxicity cervical cancer patient treat concurrent cisplatin .</brief_summary>
	<brief_title>Study With Intensity Modulated Radiation Therapy With Cisplatin Treat Stage I-IVA Cervical Cancer</brief_title>
	<detailed_description>Multiple randomize control trial establish concurrent cisplatin-based chemoradiotherapy standard care locally advanced cervical cancer [ 3-8 ] . The addition concurrent cisplatin radiotherapy ( RT ) increase pelvic control , disease-free survival ( DFS ) overall survival ; however , 5-year DFS overall survival still approximately 60 % 5-year pelvic failure approximately 30 % . Moreover , acute gastrointestinal ( GI ) hematologic toxicity increase . Approximately 30 % patient experience acute grade ≥ 3 toxicity , predominantly GI hematologic . Methods reduce toxicity chemoradiotherapy , particularly gastrointestinal hematologic , could mitigate toxicity take advantage therapeutic benefit intensive concurrent chemotherapy . Intensity modulate radiation therapy ( IMRT ) modern RT technique differs conventional technique many way . First , patient undergo compute tomography ( CT ) simulation customize target volume define 3-dimensionally . IMRT treatment plan involves multiple beam angle use computerized inverse treatment plan optimization algorithm identify dose distribution intensity pattern conform dose target , reduce radiation dose surround tissue . IMRT delivery typically accomplish use multileaf collimator , involve small motorize leaflet ( collimator ) move beam path , modulate dose intensity .</detailed_description>
	<mesh_term>Uterine Cervical Neoplasms</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<criteria>Biopsyproven , invasive squamous cell carcinoma , adenocarcinoma , adenosquamous carcinoma cervix Biopsy result positive carcinoma within 60 day prior registration FIGO clinical stage IIVA disease , base standard diagnostic workup , include : History/physical examination and/or Examination anesthesia ( indicate ) If patient status post hysterectomy , one follow condition must present : positive lymph node , positive margin , parametrial invasion , nonradical surgery ( i.e. , simple hysterectomy ) . If patient inoperable , one follow condition must present : clinical stage IB2IVA , positive lymph node nodal sample frozen section , and/or parametrial invasion Within 42 day prior registration , patient must follow , clinically indicate : examination anesthesia , cystoscopy , sigmoidoscopy , rigid proctoscopy , colonoscopy . Xray ( PA lateral ) , CT scan , PET/CT scan chest within 42 day prior registration ; CT scan , MRI , PET/CT pelvis within 42 day prior registration ; Karnofsky Performance Status 60100 Absolute neutrophil count ( ANC ) ≥ 1500 cells/mm3 ; Platelets ≥ 100,000 cells/mm3 ; Hemoglobin ≥ 10.0 g/dl ( Note : The use transfusion intervention achieve Hgb ≥ 10.0 g/dl acceptable ) ; Creatinine clearance ≥ 50 mg/dl ; Bilirubin &lt; 1.5 mg/dl ; WBC ≥ 3,000/μl ; ALT/AST &lt; 3 x ULN ; INR ≤ 1.5 Negative serum pregnancy test woman childbearing potential Prior invasive malignancy ( except nonmelanomatous skin cancer ) , unless disease free minimum 3 year ; Prior systemic chemotherapy within past three year Prior radiotherapy pelvis abdomen would result overlap radiation therapy field ; Paraaortic , inguinal , gross ( unresected ) pelvic nodal metastasis . Gross pelvic nodal metastasis define either : Radiographic evidence nodal metastasis CT MRI ( node short axis diameter &gt; 1 cm ) OR Radiographic evidence nodal metastasis diagnostic FDGPET PET/CT scan ( abnormally increase FDG uptake determine documented radiologist ) OR Biopsyproven metastasis ( e.g . needle biopsy ) undissected node Distant metastasis Unstable angina and/or congestive heart failure require hospitalization within past 6 month Hepatic insufficiency result clinical jaundice and/or coagulation defect Uncontrolled diabetes , define diabetes mellitus , opinion patient 's physician require immediate change management ; Uncompensated heart disease uncontrolled high blood pressure Acquired Immune Deficiency Syndrome ( AIDS ) base upon current CDC definition</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2014</verification_date>
	<keyword>Cervical</keyword>
	<keyword>Carcinoma</keyword>
	<keyword>Cisplatin</keyword>
	<keyword>IMRT</keyword>
	<keyword>Radiation</keyword>
	<keyword>INTERTECC</keyword>
	<keyword>International</keyword>
	<keyword>External Beam</keyword>
	<keyword>Brachytherapy</keyword>
	<keyword>LDR</keyword>
	<keyword>HDR</keyword>
	<keyword>IGRT</keyword>
	<keyword>CBCT</keyword>
</DOC>